Following months of sequential success in the Seedcorn competition, we are delighted to share that Klas Therapeutics was the Early Stage Regional Winner for Northern Ireland, a testament to our innovative work in transforming melanoma care through our patented Klas-PDT technology.
While the coveted All-Island Seedcorn title was awarded to the deserving winners at Plio Surgical, we extend our warmest congratulations to them for their outstanding achievement. It is inspiring to stand among such visionary companies who, like us, are pushing the boundaries of healthcare innovation.
Being nominated for the Overall Seedcorn Prize reinforces our belief in the transformative potential of our work. Competing in this prestigious competition has not only validated our mission but also energised us to continue striving for excellence in the fight against metastatic melanoma.
At Klas Therapeutics, we remain steadfast in our goal to revolutionise melanoma care through cutting-edge, patient-focused treatments. The recognition we have received through the Seedcorn competition fuels our determination to deliver better outcomes and hope to patients worldwide.
Thank you to InterTradeIreland for this incredible opportunity and for championing innovation across the island of Ireland. This milestone is only the beginning, and we are excited about what lies ahead.
Learn more about our journey and our innovative approach to melanoma care here https://klastherapeutics.com/our-mission/